Why is the vaping illness only being reported in the USA?
Leave a message
It's a common misconception that vaping-related lung injuries are exclusive to the United States. They are reported globally, but the major 2019 outbreak was far more concentrated and severe in the US due to specific factors.
🔍 The US Outbreak vs. Global Cases
The key differences between the 2019 U.S. outbreak of EVALI (E-cigarette or Vaping product use-Associated Lung Injury) and most reported cases elsewhere are shown in the table below:
| Feature | The 2019 U.S. EVALI Outbreak | Typical Cases Reported Outside the U.S. |
|---|---|---|
| Primary Cause | Largely linked to illicit cannabis (THC) vaping products contaminated with vitamin E acetate. | More often associated with nicotine vaping, with fewer reports of THC use. |
| Scale & Severity | Large-scale public health crisis with over 2,800 hospitalized cases and 68 deaths (as of Feb. 2020). | Individual case reports or smaller clusters; no known outbreaks of comparable scale. |
| Patient Profile | Included a high proportion of young, healthy individuals with no prior lung issues. | Clinical symptoms are similar, but gastrointestinal issues may be reported less frequently. |
| Regulatory Context | Occurred in a market with historically lighter federal regulation on e-cigarettes and THC products. | Many other regions had stricter pre-market regulations on e-cigarette ingredients and nicotine strength. |
🌎 Why the U.S. Situation Was Unique
The unique severity of the U.S. outbreak stemmed from a combination of market, regulatory, and social factors:
The Specific Culprit: Vitamin E Acetate: The U.S. CDC identified vitamin E acetate, a thickening agent used in illicit THC vape cartridges, as the primary chemical of concern. When inhaled, this oil-like substance can cause severe lung injury. Its widespread presence in the unregulated U.S. cannabis vape market was a key driver of the outbreak.
A Less-Regulated Market: At the time, the U.S. had a booming, diverse market for vaping products with less stringent federal oversight compared to places like the UK or EU. This allowed products like high-nicotine devices (with strengths up to 59mg/ml) and unregulated THC cartridges to proliferate more easily.
High Youth Usage & Media Focus: High rates of youth vaping drew significant media and public health attention. When the outbreak began, initial reports and regulatory discussions sometimes broadly implicated nicotine vaping, which later analysis showed was not the direct cause of EVALI. This intense focus contributed to the perception that it was a uniquely American crisis.
Strong Disease Surveillance: The U.S. has a robust public health surveillance system (the CDC), which rapidly identified and tracked the cluster of cases, making the outbreak highly visible.
💡 The Bigger Picture
It's crucial to understand that while the 2019 EVALI outbreak was uniquely severe, health authorities worldwide warn that all vaping carries inherent risks. The World Health Organization (WHO) states that e-cigarettes are harmful, can cause addiction, and their long-term health effects are not fully known.
The 2019 crisis was a specific event linked to contaminated products. However, other vaping-related lung injuries, such as chemical pneumonitis or "popcorn lung" from other additives, can and do occur in various countries.
If you are interested in the different approaches to e-cigarette regulation that contributed to these geographic differences, I can provide more details on that topic.
